- Home
- GERN vs SIMO Comparison
GERN vs SIMO Comparison
Compare GERN & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- SIMO
- Stock Information
- Founded
- GERN 1990
- SIMO 1995
- Country
- GERN United States
- SIMO Hong Kong
- Employees
- GERN N/A
- SIMO N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- SIMO Semiconductors
- Sector
- GERN Health Care
- SIMO Technology
- Exchange
- GERN Nasdaq
- SIMO Nasdaq
- Market Cap
- GERN 1.5B
- SIMO 1.8B
- IPO Year
- GERN 1996
- SIMO 2005
- Fundamental
- Price
- GERN $1.55
- SIMO $50.09
- Analyst Decision
- GERN Buy
- SIMO Strong Buy
- Analyst Count
- GERN 11
- SIMO 8
- Target Price
- GERN $5.80
- SIMO $80.63
- AVG Volume (30 Days)
- GERN 14.9M
- SIMO 420.6K
- Earning Date
- GERN 05-01-2025
- SIMO 05-01-2025
- Dividend Yield
- GERN N/A
- SIMO 3.94%
- EPS Growth
- GERN N/A
- SIMO 69.06
- EPS
- GERN N/A
- SIMO 2.68
- Revenue
- GERN $76,994,000.00
- SIMO $803,552,000.00
- Revenue This Year
- GERN $208.83
- SIMO $2.80
- Revenue Next Year
- GERN $57.49
- SIMO $13.32
- P/E Ratio
- GERN N/A
- SIMO $18.93
- Revenue Growth
- GERN 32386.92
- SIMO 25.72
- 52 Week Low
- GERN $1.46
- SIMO $48.81
- 52 Week High
- GERN $5.34
- SIMO $85.87
- Technical
- Relative Strength Index (RSI)
- GERN 31.37
- SIMO 39.48
- Support Level
- GERN $1.63
- SIMO $54.75
- Resistance Level
- GERN $1.89
- SIMO $56.89
- Average True Range (ATR)
- GERN 0.11
- SIMO 2.30
- MACD
- GERN 0.03
- SIMO -0.27
- Stochastic Oscillator
- GERN 0.37
- SIMO 19.01
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.